Normal Aging: Memory Problems Are Not Always A Sign Of Dementia
January 18, 2023
We’ve all experienced it. Introduced to some new people in a social setting, you feel confused as to who was whom when discussing the gathering later that evening. Or, when asked a question, it takes you longer to retrieve the answer than it previously might have. Or maybe a friend…
Sitting (Not So) Pretty: Even Brief Walks Can Counter The Negative Effects Of Excessive Sitting
January 18, 2023
It’s no secret that a sedentary lifestyle and excessive sitting can be harmful to both your physical and cognitive health. In fact, whether you continue to sit in an office, spend hours in front of the tv, or just like to relax all day on your front porch, sitting for…
How Well Do You Smell? Loss Of Smell May Spell Trouble
January 18, 2023
As we’ve highlighted in the past, loss of the sense of smell could be a warning sign that you are facing the onset of dementia or Alzheimer’s. Since that previous post, more recent studies have confirmed this suspicion and provided additional evidence of the connection. In a study published in…
Less Stress: New Research Suggests Older Adults Experience Less Stress
January 18, 2023
While for some, the vision of life as an older adult is one of retirement, relaxation, and soaking up a carefree life, most of us know the reality is not quite so rosy, even if you’ve managed to save enough money to afford a comfortable lifestyle. But many of us…
Another Win: The Mediterranean Diet Is Again Rated Best For Healthy Aging
January 11, 2023
Well, US News rankings may be under fire among college applicants, but for those concerned about healthy aging, there’s still much to be said about its health ratings of diets. Once again for the 6th year in a row, the publication has rated the Mediterranean Diet as the best diet…
Hope In A Bottle: Leqembi, The Newly Approved Alzheimer’s Medication
January 11, 2023
As a follow-up to our previous article portending the next new drug for Alzheimer’s, the FDA has now given approval under its accelerated approval pathway to the new medication Leqembi (originally known as Lecanemab). This drug was developed to help slow down cognitive decline in those with Mild Cognitive Impairment…